Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. Its lead product candidate, VCN-01 (zabilugene almadenorepvec), a clinical stage...
Leadership
Steven A. Shallcross CPA
CEO, CFO, Treasurer, Corporate Secretary & Director
Vince Wacher Ph.D.
Senior Vice President of Corporate & Product Development
